These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22170300)

  • 1. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo.
    Lin X; Yang S; Gou J; Zhao M; Zhang Y; Qi N; He H; Cai C; Tang X; Guo P
    J Mater Sci Mater Med; 2012 Feb; 23(2):443-55. PubMed ID: 22170300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
    Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB
    Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
    Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
    An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ
    Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticles produced by the hydrogel template method for sustained drug delivery.
    Lu Y; Sturek M; Park K
    Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.
    Lin X; Xu Y; Tang X; Zhang Y; Chen J; Zhang Y; He H; Yang Z
    Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
    Desai KG; Mallery SR; Schwendeman SP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
    Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X
    Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation.
    Wang L; Zheng X; Wu F; Shen L; Lin X; Feng Y
    Drug Deliv; 2018 Nov; 25(1):267-277. PubMed ID: 29334805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated removal of solvent residuals from PLGA microparticles by alcohol vapor-assisted fluidized bed drying.
    Kias F; Bodmeier R
    Int J Pharm; 2024 Nov; 665():124737. PubMed ID: 39307443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres.
    Hu Z; Liu Y; Yuan W; Wu F; Su J; Jin T
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):206-11. PubMed ID: 21524893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres.
    Selmin F; Blasi P; DeLuca PP
    AAPS PharmSciTech; 2012 Dec; 13(4):1465-72. PubMed ID: 23090111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats.
    Lu Y; Tang X; Cui Y; Zhang Y; Qin F; Lu X
    Eur J Pharm Biopharm; 2008 Feb; 68(2):422-9. PubMed ID: 17614267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Lasting
    Bazraee S; Mobedi H; Mashak A; Jamshidi A
    Curr Drug Deliv; 2022; 19(1):157-166. PubMed ID: 34139983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of initial burst in PLGA microparticles.
    Allison SD
    Expert Opin Drug Deliv; 2008 Jun; 5(6):615-28. PubMed ID: 18532918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.